Brian Mueller - 13 Dec 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
13 Dec 2022
Transactions value $
-$111,000
Form type
4
Filing time
15 Dec 2022, 17:22:45 UTC
Previous filing
06 Dec 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $158K +2.5K +9.01% $63.10 30.2K 13 Dec 2022 Direct F1
transaction BMRN Common Stock Sale -$269K -2.5K -8.27% $107.50 27.7K 13 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -2.5K -25% $0.00 7.5K 13 Dec 2022 Common Stock 2.5K $63.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.